This pharmaceutical company is a modern enterprise with over 50 years of experience. It boasts three factory sites spanning over one million square meters, housing over 30 workshops dedicated to producing a wide range of products. Their offerings include prescription medications like injectables (both lyophilized and small volume), traditional Asian medicine preparations, tablets, capsules, granules, suppositories, mixtures, and active pharmaceutical ingredients (APIs). The company prioritizes quality, holding cGMP certifications across all its workshops, along with ISO system certificates and PIC/S GMP accreditation. They serve both domestic and international markets, with a strong presence in over 60 countries across Africa, Asia, South America, and other regions. While specific therapy areas aren't mentioned, their diverse product portfolio suggests a focus on various healthcare needs.

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Established in 1993, this manufacturer employs over 1,100 staff and operates advanced production lines for metered dose inhalers, nasal sprays, dry powder inhalers, and nebulizer solutions. As a CTD dossier owner and manufacturer, it holds GMP approvals from more than 20 countries, including Australia. The manufacturer is recognized as a CTD dossier owner and manufacturer, and its products are distributed in over 90 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-end generic drugs